Compare BLTE & CWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLTE | CWST |
|---|---|---|
| Founded | 2018 | 1975 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Environmental Services |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 6.4B |
| IPO Year | 2021 | 1997 |
| Metric | BLTE | CWST |
|---|---|---|
| Price | $161.06 | $92.01 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 7 |
| Target Price | ★ $198.00 | $115.71 |
| AVG Volume (30 Days) | 153.2K | ★ 527.6K |
| Earning Date | 05-08-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,836,841,000.00 |
| Revenue This Year | N/A | $10.95 |
| Revenue Next Year | $492.11 | $6.97 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 17.95 |
| 52 Week Low | $62.18 | $74.05 |
| 52 Week High | $200.00 | $107.96 |
| Indicator | BLTE | CWST |
|---|---|---|
| Relative Strength Index (RSI) | 51.24 | 53.31 |
| Support Level | $158.32 | $85.48 |
| Resistance Level | $172.02 | $93.13 |
| Average True Range (ATR) | 6.82 | 2.56 |
| MACD | -0.74 | 0.28 |
| Stochastic Oscillator | 27.85 | 72.91 |
Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.
Casella Waste Systems Inc is a solid waste removal company, providing resource management services to residential, commercial, municipal, and industrial customers. The company's reportable segments on Geographical basis include Eastern, Western and Mid-Atlantic regions through the Resource solution segment. It generates maximum revenue from the Western region segment. The company's services include Recycling, Collection, Organics, Energy, Landfills, Special Waste as well as Professional Services.